NanoViricides Inc. (NNVC)

[crashco]

No argument intended, read or re-read Sept.4 PR. Whether the virus is encountered in the wild or via inoculation is incidental. Those who dose with Nanoviricide will achieve high levels of anti-influenza antibodies against whichever strain they encounter. And of significant importance, those who dose preventively will be "shielded" for weeks and will themselves develop anti-viral antibodies within days of an exposure.
Extrapolate beyond influenza. Medical professionals, who have always accepted risk as they battle epidemic, may finally have prophylactic protection.
Keep in mind, vaccine usage in the US is low. Globally, usage varies largely depending upon community standard of living and healthcare model. In a pandemic massive vaccine programs will be marshaled too late.